Biphasic Dissolution as an Exploratory Method During Early Drug Product Development
Dissolution testing is a major tool used to assess a drug product’s performance and as a quality control test for solid oral dosage forms. However, compendial equipment and methods may lack discriminatory power and the ability to simulate aspects of in vivo dissolution. Using low buffer capacity med...
Main Authors: | Daniela Amaral Silva, Jozef Al-Gousous, Neal M. Davies, Nadia Bou Chacra, Gregory K. Webster, Elke Lipka, Gordon L. Amidon, Raimar Löbenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/5/420 |
Similar Items
-
Shared IVIVR for Five Commercial Enabling Formulations Using the BiPHa+ Biphasic Dissolution Assay
by: Alexander Denninger, et al.
Published: (2021-02-01) -
Co-amorphization of Ibuprofen by Paracetamol for Improved Processability, Solubility, and In vitro Dissolution.
by: Mayuri S. Bhandari, et al.
Published: (2018-09-01) -
Toward Mechanistic Design of Surrogate Buffers for Dissolution Testing of pH-Dependent Drug Delivery Systems
by: Johannes Andreas Blechar, et al.
Published: (2020-12-01) -
Ibuprofen salt production and its application in tablet dosage form
by: Lannie Hadisoewignyo, et al.
Published: (2009-09-01) -
A Rational Design of a Biphasic DissolutionSetup—Modelling of Biorelevant Kinetics for a Ritonavir Hot-Melt Extruded Amorphous Solid Dispersion
by: Alexander Denninger, et al.
Published: (2020-03-01)